Granite Investment Partners »

Amphastar Pharmaceuticals shares owned by Granite Investment Partners

Quarter-by-quarter ownership of Amphastar Pharmaceuticals (AMPH) shares owned by Granite Investment Partners from 13F filings

Historical chart of Granite Investment Partners investment in Amphastar Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amphastar Pharmaceuticals held by Granite Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amphastar Pharmaceuticals by Granite Investment Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $15M 331k 45.99
2023-06-30 $31M 533k 57.47
2023-03-31 $20M 537k 37.50

More positions owned by Granite Investment Partners

Microsoft Corporation (MSFT)
Apple (AAPL)
Inter Parfums (IPAR)
Carpenter Technology Corporation (CRS)
Noble Corp Ord Shs A (NE)
Casella Waste Sys Cl A (CWST)
Freshpet (FRPT)
Cbiz (CBZ)
Halozyme Therapeutics (HALO)
Technipfmc (FTI)
Helmerich & Payne (HP)
Alphabet Cap Stk Cl C (GOOG)
Belden (BDC)
Azek Cl A (AZEK)
Amazon (AMZN)

View all positions for Granite Investment Partners

Top funds holding Amphastar Pharmaceuticals

Federated Investors
Vanguard Group
Neuberger Berman Group
Dimensional Fund Advisors
TD Asset Management
T. Rowe Price Associates
Boone Capital Management
Charles Schwab Investment Management
Oberweis Asset Management
Nordea Investment Management Ab
Bessemer
LSV Asset Management
Bank of New York Mellon
Mesirow Institutional Investment Management
Victory Capital Management

View all funds holding Amphastar Pharmaceuticals